For fifteen years, scientists possessed only ghostly DNA evidence of the Denisovans—an ancient human lineage known solely ...
Development comes as tech groups bet on potential for AI to accelerate drug discovery and uncover new materials ...
Over the course of more than two decades, researchers at the University of Bern have developed the so-called "Bern model," a suite of computer programs that can numerically simulate the formation of ...
Signet Therapeutics founder Haisheng Zhang is betting on organoids and AI to outsmart diffuse gastric cancer and the limits of traditional “clean” drug design.
Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.
Oct 1 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab, Takeda Pharmaceuticals (4502.T), opens new tab and Astex Pharmaceuticals are coming together to share proprietary data for training an ...